COVID-19 Vaccine Effectiveness Against Mortality in the Omicron Period: Evidence from Linked Mortality and Vaccination Records

Controlling for healthy vaccinee bias is crucial when estimating VE. We found limited VE against COVID-19 mortality over 2Q-4Q2022, but lacked data for more recent periods.

Institutions

Publication Details

Journal
Vaccines
Published
2025-12-11
DOI
https://doi.org/10.3390/vaccines13121235
Primary Topic
SARS-CoV-2 and COVID-19 Research
Type
article
Field-Weighted Citation Impact
0.00

Funders

Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
article

COVID-19 Vaccine Effectiveness Against Mortality in the Omicron Period: Evidence from Linked Mortality and Vaccination Records

Vaccines
SARS-CoV-2 and COVID-19 Research
article

COVID-19 Vaccine Effectiveness Against Mortality in the Omicron Period: Evidence from Linked Mortality and Vaccination Records

article en

Abstract

Controlling for healthy vaccinee bias is crucial when estimating VE. We found limited VE against COVID-19 mortality over 2Q-4Q2022, but lacked data for more recent periods.

VaccinesVol. 13(12)
Northwestern University (US), Milken Institute (US), Regenstrief Institute (US), William & Mary (US), Medical College of Wisconsin (US), University of Florida (US), Florida College (US)
National Institutes of Health, National Center for Advancing Translational Sciences
Good health and well-being
Openalex Percentile: Top 33%
SARS-CoV-2 and COVID-19 Research
DOIOpen Access PDFOpenAlex
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.